Literature DB >> 6194333

Increased susceptibility of livers of aged F344/NCr rats to the effects of phenobarbital on the incidence, morphology, and histochemistry of hepatocellular foci and neoplasms.

J M Ward.   

Abstract

Aged (875 days old) and young 42 days old) male F344/NCr rats were given sodium phenobarbital (PB) in drinking water for periods up to 233 days. Groups of aged rats were killed at 30 or 60 days or allowed to live their normal life-span, and the cause of death was determined. Young rats killed after 30, 60, and 150 days of PB exposure. Hepatocellular foci were classified into basophilic, eosinophilic, or vacuolated types according to morphologic appearance of the hepatocyte cytoplasm and were characterized by histochemical methods for the presence of gamma-glutamyl transpeptidase (GGT). The most common contributing causes of death for rats in both groups were large granular lymphocyte (LGL) leukemia and pituitary tumors. PB decreased the incidence of LGL leukemia but increased the incidence and multiplicity of hepatocellular GGT-positive foci, eosinophilic foci, and eosinophilic hepatocellular adenomas. GGT-positive eosinophilic foci increased in diameter and volume, but not in number, after appearing early in the experiment. Hepatocellular basophilic foci and neoplasms in aged control rats were usually GGT-negative and did not appear to respond to dietary PB. GGT-positive foci were seen in aged control rat livers and were composed of vacuolated amphophilic hepatocytes that differed morphologically from hepatocytes in naturally occurring liver tumors. Young rats given PB had few GGT-positive foci by 150 days on test. Aged rat livers were thus more sensitive to the effects of PB than were livers of young rats.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194333

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Nuclear receptors CAR and PXR in the regulation of hepatic metabolism.

Authors:  E S Tien; M Negishi
Journal:  Xenobiotica       Date:  2006 Oct-Nov       Impact factor: 1.908

Review 2.  Small-molecule modulators of the constitutive androstane receptor.

Authors:  Milu T Cherian; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-05-15       Impact factor: 4.481

Review 3.  Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators.

Authors:  Brian G Lake
Journal:  Toxicol Res (Camb)       Date:  2018-03-12       Impact factor: 3.524

Review 4.  Tumor promotion in the liver.

Authors:  R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

5.  Effect of age on dose-response relationship in carcinogenesis induced by single administration of N-nitrosomethylurea in female rats.

Authors:  V N Anisimov
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

6.  Phenobarbital use and bladder cancer risk.

Authors:  J E Castelao; M Gago-Dominguez; J M Yuan; R K Ross; M C Yu
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 7.  Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator.

Authors:  Clifford R Elcombe; Richard C Peffer; Douglas C Wolf; Jason Bailey; Remi Bars; David Bell; Russell C Cattley; Stephen S Ferguson; David Geter; Amber Goetz; Jay I Goodman; Susan Hester; Abigail Jacobs; Curtis J Omiecinski; Rita Schoeny; Wen Xie; Brian G Lake
Journal:  Crit Rev Toxicol       Date:  2013-11-04       Impact factor: 5.635

8.  Proliferative lesions of the glandular stomach and liver in F344 rats fed diets containing Aroclor 1254.

Authors:  J M Ward
Journal:  Environ Health Perspect       Date:  1985-05       Impact factor: 9.031

9.  Effects of phenobarbital and carbazole on carcinogenesis of the lung, thyroid, kidney, and bladder of rats pretreated with N-bis(2-hydroxypropyl)nitrosamine.

Authors:  T Shirai; A Masuda; K Imaida; T Ogiso; N Ito
Journal:  Jpn J Cancer Res       Date:  1988-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.